Professional Documents
Culture Documents
#5 Reoviridae
#5 Reoviridae
Rotavirus
- There are six species of rotavirus, referred to as A, B, C, D, E, and F
• It is non enveloped,
icosahedral, with a triple
layered capsid and a wheel-
like structure.
.
• It about 80 nm in diameter.
The VP4 forms spikes on the outer
coat and attaches the virion to the
host cell, playing a key role in cell
penetration and virulence. VP4
- The incubation period is less than 48 hours with a sudden onset of vomiting, a
high frequency of dehydration and a mean duration of diarrhoea lasting 5–6
days
- Rotavirus binds to sialic acid receptors via VP4 (HA) protein and enter cells by
endocytosis or by direct fusion
- Viral replication occur after adsorption to epithelial cells covering the vili of the
small inestne (enterocytes)
- Maximal shedding of the virus occur 2 to 5 days after the start of diarrhoea but
can occur without symptoms
- Rotavirus infection causes reduction in total small intestinal surface
area via the destruction of gut cells called enterocytes, leading to a
decrease in net fluid absorption
- The loss of fluids and electrolytes can leads to sever dehydration and
even death
The sodium glucose cotransporter-1 (SGLT-1)
serotonin (5-HT)
Prostaglandin (PG)
vasoactive intestinal peptide (VIP)
Immunity to rotavirus infection
• Rotavirus infection results in both serum
IgG and IgA and intestinal IgA responses
• The virus survives well on fomites such as furniture and toys as well as
on hands and surfaces because it can withstand drying
Who’s at risk?
• Since rotavirus is very contagious, all people can get infected.
-The purpose of the therapy is to replace fluids (elctrolytes) and correct the
acid-base imbalances
Recommended ages
-At 2 months
-At 4 months
-At 6 months (not needed if the Rotarix brand of vaccine was given at 2 and 4
months)
Rotavirus vaccine program in UK
Causing around 140,000 diarrhoea cases a year in the under-5s, rotavirus leads to
hospital stays for nearly 1 in 10 (around 14,000) of those who get it in the UK.
The oral vaccine, which is expected to halve the number of vomiting and diarrhoea
cases caused by rotavirus and lead to 70% fewer hospital stays, will be given to
infants in 2 separate doses with other routine vaccines.
Rotavirus vaccines, including the Rotarix vaccine which will be used in the UK,
are already used to routinely vaccinate children in many countries including the
US, Nicaragua and Mexico (vaccine came into use in 2006).
Studies in the US have shown that rotavirus-related hospital admissions for young
children have been cut by more than two thirds since rotavirus vaccination was
introduced